Safety, tolerability, pharmacokinetics, and efficacy of burosumab in infants with X-linked hypophosphataemia: an open-label, multicentre, non-randomised study.
- DOI
- 10.1016/s2213-8587(26)00013-6
- Published
- 2026 Jun
- Container
- The lancet. Diabetes & endocrinology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s2213-8587-26-00013-6,
title = {Safety, tolerability, pharmacokinetics, and efficacy of burosumab in infants with X-linked hypophosphataemia: an open-label, multicentre, non-randomised study.},
author = {Linglart A and Emma F and Bacchetta J and de la Cerda F and Hayes W and Cheung M and Cocca A and Högler W and Padidela R and Henderson L and Tudor A and Okada H and Sun W and Quattrocchi E},
year = {2026},
journal = {The lancet. Diabetes \& endocrinology},
doi = {10.1016/s2213-8587(26)00013-6},
url = {https://doi.org/10.1016/s2213-8587(26)00013-6}
}RIS
TY - JOUR TI - Safety, tolerability, pharmacokinetics, and efficacy of burosumab in infants with X-linked hypophosphataemia: an open-label, multicentre, non-randomised study. AU - Linglart A AU - Emma F AU - Bacchetta J AU - de la Cerda F AU - Hayes W AU - Cheung M AU - Cocca A AU - Högler W AU - Padidela R AU - Henderson L AU - Tudor A AU - Okada H AU - Sun W AU - Quattrocchi E PY - 2026 JO - The lancet. Diabetes & endocrinology DO - 10.1016/s2213-8587(26)00013-6 UR - https://doi.org/10.1016/s2213-8587(26)00013-6 ER -
APA
A, L., F, E., J, B., F, D. L. C., W, H., M, C., A, C., W, H., R, P., L, H., A, T., H, O., W, S., & E, Q. (2026). Safety, tolerability, pharmacokinetics, and efficacy of burosumab in infants with X-linked hypophosphataemia: an open-label, multicentre, non-randomised study.. The lancet. Diabetes & endocrinology. https://doi.org/10.1016/s2213-8587(26)00013-6
Source records
- pubmed · retrieved 2026-09-26T05:12:50.678Z